Literature DB >> 30251456

Percutaneous removal of benign phyllodes tumor of the breast: An alternative to surgery.

Lucía Graña López1, Manuel Vázquez Caruncho1, Ángeles Villares Armas1.   

Abstract

We aimed to evaluate the efficacy of vacuum assisted percutaneous excision in the treatment of benign phyllodes tumors of the breast. From 2007 to 2016, a total of 160 benign fibroepithelial nodules were percutaneously removed in our department. Ultrasonographic follow-up was performed 12 months after the procedure to assess recurrence. Out of the 160 nodules excised, 11 lesions corresponded to benign phyllodes tumors. The median patient age was 39.7 years. The average size of the lesion was 16.9 mm. Ultrasound-guided biopsy was performed before the percutaneous removal in eight of them. Six were histopathologically diagnosed as fibroadenomas, one as phyllodes tumor and in one case histological findings were inconclusive. The mean surveillance period was 27.7 months. During the follow-up period, local recurrence was detected in one patient (9%). We conclude that percutaneous excision of benign phyllodes tumors is not associated with greater risk of recurrence than surgery.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  benign phyllodes tumor; ultrasound; vacuum-assisted excision

Mesh:

Year:  2018        PMID: 30251456     DOI: 10.1111/tbj.13122

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  2 in total

1.  Surgical management and prognosis of phyllodes tumors of the breast.

Authors:  Yashuang Ji; Yuting Zhong; Yiqiong Zheng; Huayu Hu; Ningning Min; Yufan Wei; Rui Geng; Chenyan Hong; Qingyu Guan; Jie Li; Zhili Wang; Yanjun Zhang; Xiru Li
Journal:  Gland Surg       Date:  2022-06

2.  The treatment process of an extremely rare giant borderline phyllodes tumor of breast: case report and literature review.

Authors:  Qing Wang; Kai Zheng; Lei Zhang; Mingjian Tan; Hongwan Li; Hengyu Zhang; Dong Chen; Zhilin Li; Zhirui Chuan; Xi Wang; Yuanxiao Wang; Lei Zhe; Lijuan Liu; Dequan Liu; Rong Guo; Shicong Tang
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.